# A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

> **NCT00134173** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1100 (—)

## Conditions studied

- Coronary Disease
- Coronary Arteriosclerosis
- Hyperlipidemia

## Interventions

- **DRUG:** torcetrapib/atorvastatin
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00134173
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 1100 (—)
- **Last updated:** 2007-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134173, "A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00134173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*